botensilimab,balstilimab
agenus
new #immunotherapy kids on the block for advanced #crc? very promising data presented #wcgci2022 botensilimab and balstilimab &gt; fc enhanced ctla4/pd1 combination compelling orr of 24%
is there a role of liver mets for io efficacy? 
Physician-scientist, focussed on translational research in hepatobiliary cancer and precision medicine